The Journal of Headache and Pain, 2023 · DOI: https://doi.org/10.1186/s10194-023-01664-4 · Published: September 5, 2023
Menstrual migraine affects approximately 6% of women of reproductive age and is characterized by migraine attacks closely linked to the menstrual cycle. The prevailing theory, known as the estrogen withdrawal hypothesis, suggests that the drop in estrogen levels before menstruation triggers these attacks. However, the evidence supporting this hypothesis is limited and requires further research, focusing on the interplay between estrogen, the trigeminovascular system, and migraine.
Focus research on the pathogenesis of menstrual migraine using larger, well-defined human cohorts with consistent methodology.
Explore the potential of treatments targeting the CGRP pathway, considering the possible role of estrogen in modulating this pathway.
Recognize and address the unique clinical features of perimenstrual migraine attacks, which may require different treatment approaches.